Stroma-Driven Neuroplasticity as a Driver of Tumor Progression

Area of Science:

• Oncology
• Cancer Biology
• Neuroscience

Background:

• Pancreatic ductal adenocarcinoma (PDAC) is a complex disease with a challenging tumor microenvironment.
• The role of the nervous system in cancer progression is an emerging area of research.

Purpose of the Study:

• To investigate the role of cancer-associated fibroblasts (CAFs) in the recruitment and activation of sympathetic nerves within pancreatic cancer.
• To elucidate the mechanisms underlying the interaction between stromal cells and the nervous system in PDAC.

Main Methods:

• Utilized mouse models of pancreatic cancer.
• Employed techniques such as immunohistochemistry and single-cell RNA sequencing.
• Investigated the functional impact of targeting specific fibroblast populations.

Main Results:

• Identified myofibroblastic CAFs as key drivers of sympathetic nerve fiber infiltration and activation in PDAC.
• Uncovered a feedforward loop where CAFs promote nerve growth, and nerves, in turn, may influence fibroblast activity, creating a stromal-sympathetic circuit.
• Demonstrated that targeting these CAFs can modulate neuroplasticity within the tumor microenvironment.

Conclusions:

• Fibroblast-orchestrated neuroplasticity is a critical, therapeutically targetable process in pancreatic cancer.
• The identified stromal-sympathetic circuit offers a novel therapeutic strategy that may extend beyond PDAC to other cancer types.